Pegilodecakin
Pegilodecakin Uses, Dosage, Side Effects, Food Interaction and all others data.
Pegilodecakin is under investigation in clinical trial NCT03382912 (Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer).
| Trade Name | Pegilodecakin |
| Generic | Pegilodecakin |
| Pegilodecakin Other Names | Pegilodecakin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pegilodecakin
